Publicaciones en las que colabora con Francisco Sogorb Garri (38)

2016

  1. Is the ORBIT bleeding risk score superior to the HAS-BLED score in anticoagulated atrial fibrillation patients?

    Circulation Journal, Vol. 80, Núm. 10, pp. 2102-2108

  2. Long-term predictors of thromboembolic events in nonvalvular atrial fibrillation patients undergoing electrical cardioversion

    Circulation Journal, Vol. 80, Núm. 3, pp. 605-612

  3. The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion

    International Journal of Cardiology, Vol. 217, pp. 42-48

2015

  1. Effects of body mass index on the lipid profile and biomarkers of inflammation and a fibrinolytic and Prothrombotic state

    Journal of Atherosclerosis and Thrombosis, Vol. 22, Núm. 6, pp. 610-617

2013

  1. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

    Age and Ageing, Vol. 42, Núm. 1, pp. 70-75

2012

  1. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?

    Circulation: Cardiovascular Interventions, Vol. 5, Núm. 4, pp. 459-466

2011

  1. An evaluation of the CHADS2 stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization

    Chest, Vol. 139, Núm. 6, pp. 1402-1409

2010

  1. The prognostic value of biomarkers after a premature myocardial infarction

    International Journal of Cardiology, Vol. 143, Núm. 3, pp. 249-254

2009

  1. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation

    European Heart Journal, Vol. 30, Núm. 8, pp. 932-939

  2. Premature coronary artery disease in young (age < 45) subjects: Interactions of lipid profile, thrombophilic and haemostatic markers

    International Journal of Cardiology, Vol. 136, Núm. 2, pp. 222-225

2008

  1. Premature myocardial infarction: Clinical profile and angiographic findings

    International Journal of Cardiology, Vol. 126, Núm. 1, pp. 127-129

2007

  1. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: Implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels

    Journal of Internal Medicine, Vol. 262, Núm. 6, pp. 651-658

  2. Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes

    Cerebrovascular Diseases, Vol. 24, Núm. 4, pp. 338-342

  3. Plasma angiogenin levels in acute coronary syndromes: Implications for prognosis

    European Heart Journal, Vol. 28, Núm. 24, pp. 3006-3011

2006

  1. Antiplatelet versus anticoagulant therapies in advanced age: An unfinished task

    International Journal of Cardiology, Vol. 110, Núm. 2, pp. 271-272

  2. Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?

    Journal of Thrombosis and Thrombolysis, Vol. 21, Núm. 2, pp. 163-166

2005

  1. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction

    Journal of the American College of Cardiology, Vol. 45, Núm. 1, pp. 25-29

  2. Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain

    International Journal of Cardiology, Vol. 100, Núm. 1, pp. 151-154

  3. Efecto de dosis máximas de atorvastatina en la inflamación, la trombogénesis y la función fibrinolítica en pacientes con cardiopatía isquémica de alto riesgo

    Revista Espanola de Cardiologia, Vol. 58, Núm. 8, pp. 934-940

  4. Influence of smoking habit on cardiac functional capacity and diastolic function in healthy people [4]

    International Journal of Cardiology, Vol. 98, Núm. 3, pp. 517-518